These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8191241)

  • 1. Vasoactive intestinal polypeptide (VIP) secretion and refractory diarrhea in patients with AIDS or AIDS-related complex (ARC).
    Manfredi R; Vezzadini P; Fanti MP; Chiodo F
    Scand J Infect Dis; 1994; 26(1):55-7. PubMed ID: 8191241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma levels of vasoactive intestinal peptide in AIDS patients with refractory idiopathic diarrhoea. Effects of treatment with octreotide.
    Manfredi R; Vezzadini P; Costigliola P; Ricchi E; Fanti MP; Chiodo F
    AIDS; 1993 Feb; 7(2):223-6. PubMed ID: 8466684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide therapy in AIDS-related, refractory diarrhea: results of a multicentre Canadian-European study. Octreotide International Multicentre AIDS-Diarrhea Study.
    Montaner JS; Harris AG
    AIDS; 1995 Feb; 9(2):209-10. PubMed ID: 7718196
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of secretory diarrhea in AIDS with the somatostatin analogue SMS 201-995.
    Füessl HS; Zoller WG; Kochen MM; Bogner JR; Heinrich B; Matuschke A; Goebel FD
    Klin Wochenschr; 1989 Apr; 67(8):452-5. PubMed ID: 2724869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide therapy of large-volume refractory AIDS-associated diarrhea: a randomized controlled trial.
    Garcia Compean D; Ramos Jimenez J; Guzman de la Garza F; Saenz C; Maldonado H; Barragan RF; Michel H
    AIDS; 1994 Nov; 8(11):1563-7. PubMed ID: 7848592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide in the treatment of refractory diarrhea.
    Fried M
    Digestion; 1999; 60 Suppl 2():42-6. PubMed ID: 10207230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful management of intractable cryptosporidial diarrhea with intravenous octreotide, a somatostatin analogue.
    Kreinik G; Burstein O; Landor M; Bernstein L; Weiss LM; Wittner M
    AIDS; 1991 Jun; 5(6):765-7. PubMed ID: 1883548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide treatment in secretory and cyrptosporidial diarrhea in patients with acquired immunodeficiency syndrome (AIDS): clinical evaluation.
    Liberti A; Bisogno A; Izzo E
    J Chemother; 1992 Oct; 4(5):303-5. PubMed ID: 1479420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of endocrine and nonendocrine secretory diarrheal states with Sandostatin.
    Gaginella TS; O'Dorisio TM; Fassler JE; Mekhjian HS
    Metabolism; 1990 Sep; 39(9 Suppl 2):172-5. PubMed ID: 2205786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of severe cryptosporidium-related diarrhea with octreotide in a patient with AIDS.
    Katz MD; Erstad BL; Rose C
    Drug Intell Clin Pharm; 1988 Feb; 22(2):134-6. PubMed ID: 2894964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of octreotide on refractory AIDS-associated diarrhea. A prospective, multicenter clinical trial.
    Cello JP; Grendell JH; Basuk P; Simon D; Weiss L; Wittner M; Rood RP; Wilcox CM; Forsmark CE; Read AE
    Ann Intern Med; 1991 Nov; 115(9):705-10. PubMed ID: 1929038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma vasoactive intestinal polypeptide concentration determination in patients with diarrhea.
    Koch TR; Michener SR; Go VL
    Gastroenterology; 1991 Jan; 100(1):99-106. PubMed ID: 1983854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the somatostatin analogue (SMS-201-995), Sandostatin, for cryptosporidial diarrhoea in patients with AIDS.
    Clotet B; Sirera G; Cofan F; Monterola JM; Tortosa F; Fox M
    AIDS; 1989 Dec; 3(12):857-8. PubMed ID: 2517207
    [No Abstract]   [Full Text] [Related]  

  • 14. SMS 201-995, a somatostatin analogue, and diarrhea in the acquired immunodeficiency syndrome (AIDS).
    Robinson EN; Fogel R
    Ann Intern Med; 1988 Oct; 109(8):680-1. PubMed ID: 2901819
    [No Abstract]   [Full Text] [Related]  

  • 15. Intractable diarrhoea in a patient with vasoactive intestinal peptide-secreting neuroblastoma. Attempted control by somatostatin.
    Tiedemann K; Pritchard J; Long R; Bloom SR
    Eur J Pediatr; 1981 Oct; 137(2):217-9. PubMed ID: 6118274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intractable diarrhea in children with VIP-secreting ganglioneuroblastomas.
    El Shafie M; Samuel D; Klippel CH; Robinson MG; Cullen BJ
    J Pediatr Surg; 1983 Feb; 18(1):34-6. PubMed ID: 6834224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Try this drug when AIDS-related diarrhea won't quit.
    RN; 1994 Dec; 57(12):71. PubMed ID: 7817143
    [No Abstract]   [Full Text] [Related]  

  • 18. Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhea.
    Simon DM; Cello JP; Valenzuela J; Levy R; Dickerson G; Goodgame R; Brown M; Lyche K; Fessel WJ; Grendell J
    Gastroenterology; 1995 Jun; 108(6):1753-60. PubMed ID: 7768380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS enteropathy: occult enteric infections and duodenal mucosal alterations in chronic diarrhea.
    Greenson JK; Belitsos PC; Yardley JH; Bartlett JG
    Ann Intern Med; 1991 Mar; 114(5):366-72. PubMed ID: 1992878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term therapy of a metastasizing pancreatic vipoma using the somatostatin derivative octreotide].
    Flückiger A; Schlup P
    Schweiz Med Wochenschr; 1992 Aug; 122(33):1221-3. PubMed ID: 1326786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.